- SynPharm: An electric 'vade mecum' for manipulators of biological signaling
May 22, 2017
BY: Jamie Davies
- Molecular modeling relies on computers to help design molecules that might lead us to tomorrow’s drug. The types of modelers who occupy this space are as varied as the techniques,
April 25, 2017
BY: David Clark
- Why spring smells like it does, are we closer to solving Huntington’s and reprogramming blood stem cells.
May 19, 2017
BY: Jillian Scola
- Scientist Alicia Ryberg immerses herself in the culture of Nicaragua and gains a much greater perspective than she ever anticipated. An ongoing series about Charles River sabbaticals.
May 18, 2017
BY: Alicia Ryberg
- In drug discovery for rare diseases, gene therapies are beginning to show clinical promise. Will the strategy pay off? A report from a Charles River symposium
May 16, 2017
BY: Regina McEnery
- A potential cure for gluten sensitivities, can tracking a cancer tumor lead to a cure and is artificial sweetener making you chubby?
May 12, 2017
BY: Jillian Scola
- After routine chemotherapy loses steam, ovarian cancer survivor Beth Hoover finds a reprieve with targeted therapy and a clinical trial. A Eureka Moments story.
May 11, 2017
BY: Regina McEnery
- The creatures we fear are also aiding the development of drugs for diabetes, cancer, neurological disorders and inflammatory diseases.
May 8, 2017
BY: Andy Vick
- Seeing your face in 3D, the science behind losing an eye and can sweat offer up important clues about our health?
May 5, 2017
BY: Jillian Scola
- How the gene editing system known as CRISPR-Cas9 is transforming how we create animal models of disease.
May 3, 2017
BY: Eureka Staff